4//SEC Filing
OSIRIS THERAPEUTICS, INC. 4
Accession 0001179110-14-014805
CIK 0001360886operating
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 6:40 AM ET
Size
9.5 KB
Accession
0001179110-14-014805
Insider Transaction Report
Form 4
Neumayer Matthew Paul
Principal Accounting Officer
Transactions
- Disposition to Issuer
Incentive Stock Option (right to buy)
2014-09-30$7.73/sh−2,625$20,291→ 0 totalExercise: $7.73From: 2015-02-12Exp: 2014-09-30→ Common Stock (2,625 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2014-09-30$5.08/sh−1,750$8,890→ 2,625 totalExercise: $5.08From: 2015-03-23Exp: 2014-09-30→ Common Stock (1,750 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2014-09-30$7.13/sh−1,000$7,130→ 4,375 totalExercise: $7.13From: 2015-02-14Exp: 2014-09-30→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]Unvested stock options that were forfeited concurrent with the Reporting Person's termination from employment with the Registrant, consistent with the provisions of the Amended and Restated 2006 Omnibus Plan.
Documents
Issuer
OSIRIS THERAPEUTICS, INC.
CIK 0001360886
Entity typeoperating
IncorporatedMD
Related Parties
1- filerCIK 0001360886
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 6:40 AM ET
- Size
- 9.5 KB